At CASTR Alliance, our mission is to facilitate the discovery of novel ways to treat disease in human and veterinary patients. As clinical researchers, our work streamlines device and therapeutic development for animal and human patients alike, with the goal of bringing important solutions to market sooner. We connect biomedical discovery with veterinarians and their patients while providing turnkey management of sponsored veterinary studies.
Through our relationships with state-of-the-art veterinary specialty and referral hospitals in the Pacific Northwest and beyond, we link companion animals in need of innovative medicines with novel therapeutic options that may otherwise be unavailable to them.
When taking care of our pets also means advancing human healthcare, everyone wins. That's the benefit of translational research.
Clinical studies in companion animal patients - our pets - can be conducted with greater speed and efficiency, and often at a fraction of the cost of human clinical trials. CASTR provides a solution for those companies challenged by the traditionally expensive and inefficient drug development process. We offer expertise in conducting companion animal clinical studies and access to a network of veterinary specialists and clinics that can reach precisely those animals that can both benefit from and provide insight into new treatments.
CASTR was specifically founded to provide standardized study execution that meets or exceeds the requirements of both biopharmaceutical companies and regulatory agencies. Our studies abide by the Good Clinical Practice (GCP) standards for veterinary studies and are designed and conducted to ensure the rights, safety, and well-being of all patients.
As a clinical research organization, or CRO, we strive to reduce costs and accelerate timelines for biomedical and pharmaceutical companies developing new medicines, devices, and therapies for humans and animals.
With CASTR Alliance, companies or organizations seeking to evaluate the efficacy of a new drug product or device benefit from high-quality data that can be used to determine feasibility and direct further research.
While lab-based research often relies upon the artificial induction of disease, our research focuses on spontaneous diseases - those that arise naturally in our dogs and cats. By treating animals who are already afflicted or symptomatic, we're able to provide direct benefits to our pets, while assessing the potential of a drug for use in other animals or humans.
When you enroll your animal in a clinical trial, you not only provide a potential service to your pet, you take part in helping accelerate discovery and innovation in veterinary care and human medicine.
Our extensive network provides our clients with access to:
Studies with companion animals provide a vast array of benefits that differentiate them from human trials.
Contracting companies can expect all studies to be managed efficiently and compassionately, and result in high quality data. We deliver progress updates on trial status, study management, and site monitoring, and provide results and analysis on demand, and at the conclusion of the trial.
At the outset, we train participating veterinary clinicians on the trial protocol to ensure treatment is conducted according to our rigorous standards, then we continue to provide ongoing guidance to these clinicians throughout the entire course of the study.
As a pet owner, you'll work directly through your veterinary care provider or specialist, who will administer treatment according to the protocol.
CASTR Alliance was founded by veterinary clinician-scientists Jessica Bertout and Jim Perry. As scientists, they have broad experience designing, managing, and conducting clinical trials that meet the stringent requirements of the biotech industry. Importantly, as dedicated pet owners and veterinarians, they’re personally invested in providing the best possible care to our animal companions. Together, Drs. Bertout and Perry created CASTR Alliance to leverage their expertise and advance medicine for humans and animals alike.
Cancer biologist and veterinarian Jessica Bertout completed her undergraduate degree in biology at Yale, her VMD and PhD in Biology at the University of Pennsylvania, and postdoctoral studies in cancer biology at the Fred Hutchinson Cancer Research Center. Dr. Bertout went on to manage multi-site clinical trials in both canine and human patients for Seattle-based biotech company Presage Biosciences before co-founding CASTR Alliance. Dr. Bertout has more than 15 years of experience in cancer biology and a passion for clinical research.LinkedIn
Veterinary oncologist and surgeon Jim Perry earned his undergraduate degree at the University of Washington. He completed his DVM and PhD in Immunology, postdoctoral studies and medical oncology residency at Colorado State University, and his surgical residency at Aspen Meadow Veterinary Specialists in Longmont, Colorado. Dr. Perry is board-certified both in medical oncology and in small animal surgery. In addition to his role at CASTR Alliance, Inc., he continues to see patients as a surgical oncologist at Veterinary Cancer and Surgery Specialists near Portland, Oregon.LinkedIn
Contact us for more information about our clinical research services.